Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Clinical Rheumatology|February 15, 2011
Sonographic subclinical entheseal involvement in dialysis patientsMarwin Gutierrez, Matthias Zeiler, Emilio Filippucci, et al.Clinical and Experimental Rheumatology|September 5, 2015
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosisRoberta Gualtierotti, Francesca Ingegnoli, Rebecca Two, et al.Journal of Psoriasis and Psoriatic Arthritis|April 23, 2026
Subclinical Enthesitis in Psoriasis Patients as Predictors of Arthritis: The EPESCA StudyEleonora Di Donato, Andrea Becciolini, Sergio Di Nuzzo, et al.Seminars in Arthritis and Rheumatism|April 18, 2017
Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.Autoimmunity Reviews|October 20, 2018
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian expertsEnnio Giulio Favalli, Andrea Becciolini, Roberto Caporali, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 4, 2026
Post-stroke epilepsy in revascularized versus not revascularized stroke patients: a prospective cohort studyStefania Lazzari, Carlotta Mutti, Francesca Bozzetti, et al.Rheumatology International|August 23, 2019
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohortEnnio G Favalli, Andrea Becciolini, Antonio Carletto, et al.Journal of Personalized Medicine|March 25, 2022
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective AnalysisAndrea Becciolini, Simone Parisi, Rosalba Caccavale, et al.Seminars in Arthritis and Rheumatism|November 27, 2015
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.Journal of Clinical Medicine|February 15, 2022
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term StudySimone Parisi, Andrea Becciolini, Maria Chiara Ditto, et al.Pageof 7